DERZUVUS
Live / Registered — Registered (as of 24 Aug 2021)
What this means for you
Registered since 24 Aug 2021. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 declaration of use is due by 24 Aug 2027, and its filing window is open now).
Record
- Serial number
- 90328720
- Registration number
- 6461768
- Mark type
- Word mark
- Filed
- 18 Nov 2020
- Published for opposition
- 08 Jun 2021
- Registered
- 24 Aug 2021
- Next maintenance filing
- §8 declaration of use, due by 24 Aug 2027 (grace period to 24 Feb 2028)
- Attorney of record
- Evan A. Raynes
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products and preparations for human use for the treatment and prevention of cancer; pharmaceutical products and preparations for the treatment of cancer
Owner
- BASILEA PHARMACEUTICA INTERNATIONAL AG, ALLSCHWIL, ALLSCHWIL, CH
- Basilea Pharmaceutica International AG, Basel, CH
- Basilea Pharmaceutica International AG, Basel, CH
- Basilea Pharmaceutica International AG, Basel, CH
Prosecution history
- 24 Aug 2026 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 28 Jun 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 24 Aug 2021 — REGISTERED-PRINCIPAL REGISTER
- 08 Jun 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Jun 2021 — PUBLISHED FOR OPPOSITION
- 19 May 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 May 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 Apr 2021 — ASSIGNED TO EXAMINER
- 31 Mar 2021 — PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
- 30 Mar 2021 — ASSIGNED TO LIE
- 22 Jan 2021 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 28 Dec 2020 — TEAS VOLUNTARY AMENDMENT RECEIVED
- 21 Nov 2020 — NEW APPLICATION ENTERED